Ryan Fukushima Sells 5,000 Shares of Tempus AI (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 5,000 shares of the company’s stock in a transaction on Monday, October 6th. The shares were sold at an average price of $92.32, for a total value of $461,600.00. Following the completion of the sale, the chief operating officer owned 130,000 shares in the company, valued at $12,001,600. This trade represents a 3.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Ryan Fukushima also recently made the following trade(s):

• On Tuesday, August 19th, Ryan Fukushima sold 17,460 shares of Tempus AI stock. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $99.28 on Friday. The business’s fifty day moving average price is $78.06 and its two-hundred day moving average price is $64.44. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The stock has a market capitalization of $17.25 billion, a price-to-earnings ratio of -83.43 and a beta of 4.87. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million for the quarter, compared to analysts’ expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business’s revenue for the quarter was up 89.5% on a year-over-year basis. During the same quarter in the prior year, the business earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Tempus AI

Several large investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. lifted its stake in Tempus AI by 12.7% in the first quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company’s stock valued at $89,000 after buying an additional 208 shares during the period. China Universal Asset Management Co. Ltd. lifted its stake in Tempus AI by 0.7% in the second quarter. China Universal Asset Management Co. Ltd. now owns 33,757 shares of the company’s stock valued at $2,145,000 after buying an additional 226 shares during the period. PNC Financial Services Group Inc. lifted its stake in Tempus AI by 6.1% in the second quarter. PNC Financial Services Group Inc. now owns 5,003 shares of the company’s stock valued at $318,000 after buying an additional 287 shares during the period. Concord Wealth Partners lifted its stake in Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock valued at $26,000 after buying an additional 308 shares during the period. Finally, Sigma Planning Corp lifted its stake in Tempus AI by 1.0% in the second quarter. Sigma Planning Corp now owns 33,834 shares of the company’s stock valued at $2,150,000 after buying an additional 319 shares during the period. Institutional investors and hedge funds own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on TEM. Bank of America increased their target price on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday. HC Wainwright increased their target price on Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a report on Friday, September 12th. BTIG Research upped their price target on Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a research note on Wednesday, August 20th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Tempus AI presently has an average rating of “Hold” and a consensus price target of $71.83.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.